Concern over rise in alcohol-related harm in city
Incidents of anti-social behaviour in York city centre's alcohol restriction zone went up over the past year, councillors have been told.
The most recent statistics also showed the city had seen a higher number of alcohol-related hospital admissions than the England average, according to a report seen by councillors into the impact of licensed premises.
Rachel Melly, chair of City of York Council's licensing and regulatory committee, told a meeting that "alcohol-related harm is a concern".
The data would be taken into account when the council updated its licensing policy later in the year, she said.
Discussing the authority's draft licensing policy statement for 2025-30, councillors heard that anti-social behaviour in York city centre's alcohol restriction zone - where it is an offence for a person to continue consuming alcohol when requested to stop doing so by a police officer - rose by 15% in the last year.
Meanwhile, the city had seen 1,908 alcohol-related hospital admissions per 100,000 people in 2022-23, which the council's licensing committee was told was "significantly higher" than the England-wide rate for the same period.
The report stated that an increasing number of pubs and bars were now offering activities such as "bottomless brunches", with unlimited drinks and food for a set period.
According to the Local Democracy Reporting Service, councillors were told that another trend in the past five years was bar staff walking around and offering shots of spirits to customers.
Council officers said that had led to people consuming large amounts of alcohol and fuelling the increase in anti-social behaviour.
In response to a consultation on the authority's plans to update its licensing policy, one bar owner called for alcohol-related problems to be handled better by police and the council.
They said: "We have a thriving student population and a reputation in the city of good pubs and licensed premises.
"But, I fear if this situation isn't better-controlled we will lose this, and I hope it will not take a very bad incident for the council to wake up and deal with this."
Another bar owner commented: "York's charm lies in its historic appeal, unique character, and vibrant but balanced nightlife."
Responding to the consultation submissions, a council spokesperson said that its policies encouraged venues to promote customer safety and to work with them and the police to tackle problems.
"We are aware York is a popular city for day trippers and weekend visitors, due to our excellent rail links, who come to the city to visit the pubs and bars which can create an increase in anti-social behaviour," they said.
The authority had "worked with partners and the licence trade to tackle the issues associated with these, such as introducing a code of conduct", the spokesperson added.
During the meeting, Melly told councillors: "Alcohol consumption is related to crime, anti-social behaviour, domestic abuse, health problems and even death.
"So, when we were updating the licensing policy, all of the concerns and the data about this impact on the people of York was closely considered."
A consultation on the plans to update the city's licensing policy would be discussed at a further meeting, Melly told councillors.
Listen to highlights from North Yorkshire on BBC Sounds, catch up with the latest episode of Look North.
Alcohol fuels more than half of city centre crimes
'Hen parties love York because the city is safe'
MP branded 'anti fun' over bar licence comments
City of York Council
Local Democracy Reporting Service
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 hours ago
- Yahoo
Jolly Rancher candies pulled from shelves in UK over cancer concerns
Health officials in the United Kingdom are warning customers to throw away certain Jolly Rancher candies due to ingredients that may increase the risk of cancer. The candies, made by the Hershey Company, include Jolly Rancher Hard Candy, Jolly Rancher Misfits Gummies, Jolly Rancher Hard Candy Fruity 2 in 1, and Jolly Rancher Berry Gummies, the Food Standards Agency, a government department in the United Kingdom, said. The Jolly Rancher candies were sold in England, Northern Ireland and Wales, the agency said in the announcement on Wednesday, June 11. The products contain mineral oil aromatic hydrocarbons (MOAH) and mineral oil saturated hydrocarbons (MOSH), which violate UK laws, thus making the candies unsafe to consume, according to the agency. 'Food businesses who import these products are advised to discontinue import and distribution of products,' the agency said. 'Food businesses selling these products in the UK are advised to immediately stop sales, undertake product withdrawals and where there have been retail sales, to undertake product recalls.' The Hershey Company has removed the products from the UK market, the Food Standards Agency said. Previously in 2024, the Hershey Company tried to remove unsafe products from UK markets and decided not to sell the products in the country going forward, the agency said. However, some businesses continued to import the products, so the agency has asked authorities in the UK to remove the products in order to protect customers. When contacted by USA TODAY on Thursday, June 12, a spokesperson for the Hershey Company commented on whether the UK's alert could affect the sale of Jolly Rancher candies in the U.S. According to the spokesperson's statement, the safety and quality of Jolly Rancher products are the company's first priority, and "consumers can rest assured that our products are safe to enjoy." Since the Hershey Company is a global brand, customers can sometimes buy products in markets other than those the products were produced in, the spokesperson added. "In such cases, we cannot guarantee that the products meet the regulatory requirements of the end market, which may differ from those of the US," the statement reads. "We encourage consumers to purchase all Hershey products from established retailers to ensure product integrity and compliance. In the meantime, we're continuing to work closely with the FSA in the United Kingdom on these important issues and look forward to bringing Jolly Rancher products back to established retailers soon." The Food Standards Agency said that customers who have eaten the candy have likely had low exposure to the harmful ingredients. However, eating the candy is a 'toxicological concern, especially in younger age groups and where consumers eat a lot of the products or eat them regularly.' Mineral oil aromatic hydrocarbons (MOAH) have the potential to increase the risk of cancer if consumed in high quantities over a prolonged period of time, the agency said. It is a genotoxic carcinogen, meaning it can induce cancers by directly impacting DNA, and even at low levels, some damage to genetic material may increase the chance of developing cancer, per the Centre for Food Safety in Hong Kong. 'We are asking enforcement authorities to make immediate contact with businesses who may have been supplied with or received the affected products, and to take action to ensure that the non-compliant and potentially unsafe products are withdrawn from the market and where sold at retail, recalled,' the Food Standards Agency said. Customers in the UK should not buy the products, the Food Standards Agency said, adding that if they've eaten them, 'there should be no immediate cause for concern, as food safety risk is low, but don't eat any more." UK customers should get rid of the candies, and if they are concerned, notify their Trading Standards department or their environmental health department where they purchased the items. 'These products contain mineral oil, which isn't allowed in food in the UK and may pose a food safety risk if consumed regularly over a sustained period of time,' the agency said. Saleen Martin is a reporter on USA TODAY's NOW team. She is from Norfolk, Virginia – the 757. Email her at sdmartin@ This article originally appeared on USA TODAY: Jolly Rancher candies deemed unsafe in UK over cancer concerns
Medscape
20 hours ago
- Medscape
RCGP Urges Support to Save Declining GP Partnership Model
The Royal College of General Practitioners (RCGP) has warned that GP partnerships are under threat, as the number of partners in England has dropped by 25% over the past decade. In a new report, the college urged action to 'break down barriers to partnership' and called for modernisation of the model to make it more attractive to younger doctors. While the RCGP reaffirmed its support for the independent contractor model, it said there was 'room for modernisation and innovation', and backed ' a mixed economy' of contractual models to deliver general practice. Shift in Workforce Between 2015 and 2025, the number of GP partners in England fell from 24,491 to 18,367. Over the same period, the number of salaried GPs rose by 81%, from 10,270 in September 2015 to 18,557 in December 2024. As of June 2024, GP partners were a minority among fully qualified GPs for the first time. The most significant drop in partnership was seen in younger doctors. Among GPs aged 30-34, numbers fell by 72.9%. The only age group to show growth was those aged 60-64, up by 19.5%. Barriers to Partnership Rising workload, administrative burdens, and concerns about financial risk were cited as major deterrents to partnership. Professor Kamila Hawthorne, RCGP chair, said that many GPs were discouraged by the unlimited personal liability that comes with being a partner. She also pointed to the responsibilities of owning or leasing premises and managing staff, especially as patient demand increases. Exploring Alternatives The RCGP report explored alternative business models that could support general practice, including limited companies, limited liability partnerships (LLPs), and community benefit societies. The college maintained that partnerships still offered flexibility and potential for innovation, particularly if financial and workload pressures could be reduced. In 2024, more than half (55%) of RCGP members said they would be more likely to consider partnership if financial risks were lower. A review by Lord Darzi highlighted the financial discipline of GP partnerships, noting that they could not run large deficits like other parts of the NHS. Earlier this year, the Nuffield Trust described the current GP partnership model as 'withering'. The health think tank warned that the government's plans to improve GP access were at risk due to the fall in partner numbers. Thea Stein, chief executive of the Nuffield Trust, told Medscape News UK : 'It is hard to see partnership being the dominant model in the future.' She called for support where the model works well, but said new models must also be explored. Hawthorne maintained that 'there are elements of the traditional GP partnership that can be improved and modernised, while retaining its core strengths'. The GP partnership model has huge benefits for the NHS and for patients, she added. Government Response A Department of Health and Social Care (DHSC) spokesperson acknowledged the strengths of the partnership model, including efficiency, innovation, and continuity of care. 'However, we also recognise that this is not the only model delivering general practice,' the spokesperson told Medscape News UK . 'GP practices can choose to organise themselves in different ways and also provide good outcomes in terms of staff engagement and patient experience.'
Yahoo
a day ago
- Yahoo
NHS waiting list for planned treatment falls to lowest level in two years
The NHS waiting list for planned hospital treatment has fallen to its lowest level for two years, figures show. An estimated 7.39 million treatments were waiting to be carried out at the end of April, relating to 6.23 million patients – down from 7.42 million treatments and 6.25 million patients at the end of March. These are the lowest figures since March 2023 for treatments and April 2023 for patients. The news comes after Chancellor Rachel Reeves gave the NHS a cash injection worth an extra £29 billion per year. Health and Social Care Secretary Wes Streeting said: 'We are putting the NHS on the road to recovery after years of soaring waiting times, by providing record investment and fundamental NHS reform. 'Thanks to our interventions and the hard work of NHS staff, the overall waiting list has now fallen in April for the first time in 17 years – dropping by almost a quarter of a million since we took office. 'This is just the start. We've delivered millions of extra appointments since July, we are pushing on with our mission to get the NHS working for patients once again as we deliver our Plan for Change.' Within the new NHS figures, the number of longer waits has grown. Some 1,361 patients in England had been waiting more than 18 months to start routine treatment at the end of April, up from 1,164 in March. There were 9,258 patients who had been waiting more than 65 weeks to start treatment, up from 7,381 the previous month. Overall, 190,068 people in England had been waiting more than 52 weeks to start routine hospital treatment, up from 180,242 at the end of March. The figure had previously fallen for 10 months in a row. NHS England said that, overall, the average time patients had been waiting for planned treatment fell to the lowest level since July 2022 – 13.3 weeks – despite services facing greater demand. Meghana Pandit, NHS England's co-national medical director, said NHS staff were working to 'turn the tide for patients waiting for care'. She said while huge pressure on services remains, 'we are starting to see a real difference across our services – this is just the start of the work we're doing to reform care and deliver improvements for patient'. The data also showed fewer people are getting a diagnosis of cancer or having it ruled out within four weeks. A total of 76.7% of patients urgently referred for suspected cancer were diagnosed or had cancer ruled out within 28 days in April, down from 78.9% in March and 80.2% in February. The Government and NHS England had set a target of March 2026 for this figure to reach 80%. The proportion of patients who had waited no longer than 62 days in April from an urgent suspected cancer referral, or consultant upgrade, to their first definitive treatment for cancer was 69.9%, down from 71.4% in March. GPs in England made 264,880 urgent cancer referrals in April, down from 272,165 in March but up year-on-year from 260,516 in April 2024.
